Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity

被引:22
作者
Cheng, Hanyin [1 ,2 ]
Ross, Jeremy A. [1 ]
Frost, Jeffrey A. [2 ]
Kirken, Robert A. [1 ]
机构
[1] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79902 USA
[2] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston Med Sch, Houston, TX 77030 USA
关键词
D O I
10.1128/MCB.01789-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Janus tyrosine kinase 3 (Jak3) is essential for signaling by interleukin-2 (IL-2) family cytokines and proper immune function. Dysfunctional regulation of Jak3 may result in certain disease states. However, the molecular mechanisms governing Jak3 activation are not fully understood. In this study, we used a functional-proteomics approach to identify two novel tyrosine phosphorylation sites within Jak3, Y904 and Y939, which are conserved among Jak family proteins. By using phosphospecific antibodies, both residues were observed to be rapidly induced by stimulation of cells with IL-2 or other gamma c cytokines. Mechanistic studies indicated that Y904 and Y939 regulate Jak3 activities. A phenylalanine substitution at either site greatly reduced Jak3 kinase activity in vitro and its ability to phosphorylate signal transducer and activator of transcription 5 (Stat5) in vivo, suggesting that phosphorylation of these previously unrecognized residues positively regulates Jak3 activity. Y904 and Y939 were required for optimal ATP usage by Jak3, while phosphorylation of Y939 preferentially promoted Stat5 activity in intact cells. Together, these findings demonstrate positive functional roles for two novel Jak3 phosphoregulatory sites which may be similarly important for other Jak family members. Identification of these sites also provides new therapeutic opportunities to modulate Jak3 function.
引用
收藏
页码:2271 / 2282
页数:12
相关论文
共 47 条
[1]
A road map for those who don't know JAK-STAT [J].
Aaronson, DS ;
Horvath, CM .
SCIENCE, 2002, 296 (5573) :1653-1655
[2]
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[3]
Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity [J].
Argetsinger, LS ;
Kouadio, JLK ;
Steen, H ;
Stensballe, A ;
Jensen, ON ;
Carter-Su, C .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (11) :4955-4967
[4]
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog [J].
Boggon, TJ ;
Li, YQ ;
Manley, PW ;
Eck, MJ .
BLOOD, 2005, 106 (03) :996-1002
[5]
Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein [J].
Carpino, N ;
Kobayashi, R ;
Zang, H ;
Takahashi, Y ;
Jou, ST ;
Feng, J ;
Nakajima, H ;
Ihle, JN .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (21) :7491-7500
[6]
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].
Changelian, PS ;
Flanagan, ME ;
Ball, DJ ;
Kent, CR ;
Magnuson, KS ;
Martin, WH ;
Rizzuti, BJ ;
Sawyer, PS ;
Perry, BD ;
Brissette, WH ;
McCurdy, SP ;
Kudlacz, EM ;
Conklyn, MJ ;
Elliott, EA ;
Koslov, ER ;
Fisher, MB ;
Strelevitz, TJ ;
Yoon, K ;
Whipple, DA ;
Sun, JM ;
Munchhof, MJ ;
Doty, JL ;
Casavant, JM ;
Blumenkopf, TA ;
Hines, M ;
Brown, MF ;
Lillie, BM ;
Subramanyam, C ;
Shang-Poa, C ;
Milici, AJ ;
Beckius, GE ;
Moyer, JD ;
Su, CY ;
Woodworth, TG ;
Gaweco, AS ;
Beals, CR ;
Littman, BH ;
Fisher, DA ;
Smith, JF ;
Zagouras, P ;
Magna, HA ;
Saltarelli, MJ ;
Johnson, KS ;
Nelms, LF ;
Des Etages, SG ;
Hayes, LS ;
Kawabata, TT ;
Finco-Kent, D ;
Baker, DL ;
Larson, M .
SCIENCE, 2003, 302 (5646) :875-878
[7]
Activation of Jak2 catalytic activity requires phosphorylation of Y-1007 in the kinase activation loop [J].
Feng, J ;
Witthuhn, BA ;
Matsuda, T ;
Kohlhuber, F ;
Kerr, IM ;
Ihle, JN .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2497-2501
[8]
Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2 [J].
Funakoshi-Tago, Megumi ;
Pelletier, Stephane ;
Matsuda, Tadashi ;
Parganas, Evan ;
Ihle, James N. .
EMBO JOURNAL, 2006, 25 (20) :4763-4772
[9]
Signaling by Type I and II cytokine receptors: ten years after [J].
Gadina, M ;
Hilton, D ;
Johnston, JA ;
Morinobu, A ;
Lighvani, A ;
Zhou, YJ ;
Visconti, R ;
O'Shea, JJ .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (03) :363-373
[10]
The N-termini of FAK and JAKs contain divergent band 4.1 domains [J].
Girault, JA ;
Labesse, G ;
Mornon, JP ;
Callebaut, I .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :54-57